pirtobrutinib,sacituzumab,ibrutinib,venetoclax,warfarin,zanubrutinib
abbvie,eli lilly,beigene,roche,gilead,janssen
[' sg ', 'warfarin', 'caveat', 'zanubrutinib', 'cll', 'pirto', 'zanu ', ' ibru', 'alpine']
brown alpine rct #ash22 zanu v ibr in rr #cll
n=652
orr 86% v 76%
2ypfs 80% v 63%. os equiv, prob always will be
cardiac tox lower with zanu, no cardiac death v 6 in ibr (2%)!
one caveat: dead kinase muts common after zanu, ?compromise later pirto? see: 
Doc from Melbourne, Australia. Treats patients with blood cancers and researches new therapies. Loves family, immersive theatre and running.